Follow
Mohit Verma, Phd
Mohit Verma, Phd
Unknown affiliation
Verified email at immunitybio.com
Title
Cited by
Cited by
Year
Sex steroid receptors in human lung diseases
MK Verma, Y Miki, H Sasano
The Journal of steroid biochemistry and molecular biology 127 (3-5), 216-222, 2011
542011
Aromatase in human lung carcinoma
MK Verma, Y Miki, H Sasano
Steroids 76 (8), 759-764, 2011
472011
Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome
MK Verma, Y Miki, K Abe, S Nagasaki, H Niikawa, S Suzuki, T Kondo, ...
Life sciences 91 (15-16), 800-808, 2012
432012
A next generation bivalent human Ad5 COVID-19 vaccine delivering both spike and nucleocapsid antigens elicits Th1 dominant CD4+, CD8+ T-cell and neutralizing antibody responses
A Rice, M Verma, A Shin, L Zakin, P Sieling, S Tanaka, H Adisetiyo, J Taft, ...
BioRxiv, 2020.07. 29.227595, 2020
362020
Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice
A Rice, M Verma, A Shin, L Zakin, P Sieling, S Tanaka, J Balint, K Dinkins, ...
Scientific Reports 11 (1), 14917, 2021
302021
Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor
MK Verma, Y Miki, K Abe, T Suzuki, H Niikawa, S Suzuki, T Kondo, ...
Journal of Translational Medicine 11, 1-11, 2013
262013
A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo
MK Verma, J Clemens, L Burzenski, SB Sampson, MA Brehm, DL Greiner, ...
Journal of immunological methods 446, 47-53, 2017
232017
Humanized mice in translational immunology
MA Brehm, R Bortell, M Verma, LD Shultz, DL Greiner
Translational immunology: mechanisms and pharmacological approaches, 285-326, 2016
182016
Dual-antigen COVID-19 vaccine subcutaneous prime delivery with oral boosts protects NHP against SARS-CoV-2 challenge
E Gabitzsch, JT Safrit, M Verma, A Rice, P Sieling, L Zakin, A Shin, ...
Frontiers in Immunology, 3634, 2021
162021
Complete protection of nasal and lung airways against SARS-CoV-2 challenge by antibody plus Th1 dominant N-and S-specific T-cell responses to subcutaneous prime and thermally …
E Gabitzsch, JT Safrit, M Verma, A Rice, P Sieling, L Zakin, A Shin, ...
bioRxiv, 2020.12. 08.416297, 2020
162020
Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma
MK Verma, Y Miki, K Abe, H Niikawa, H Sasano
Expert Opinion on Therapeutic Targets 16 (sup1), S91-S102, 2012
152012
Prime hAd5 spike+ nucleocapsid vaccination induces ten-fold increases in mean T-cell responses in phase 1 subjects that are sustained against spike variants
P Sieling, T King, R Wong, A Nguyen, K Wnuk, E Gabitzsch, A Rice, ...
medRxiv, 2021.04. 05.21254940, 2021
142021
Heterologous saRNA prime, DNA dual-antigen boost SARS-CoV-2 vaccination elicits robust cellular immunogenicity and cross-variant neutralizing antibodies
A Rice, M Verma, E Voigt, P Battisti, S Beaver, S Reed, K Dinkins, S Mody, ...
Frontiers in Immunology 13, 910136, 2022
72022
Anti covid-19 therapies using nucleocapsid and spike proteins
A Rice, M Verma
US Patent App. 17/405,393, 2022
72022
The Dual-Antigen Ad5 COVID-19 Vaccine Delivered as an Intranasal Plus Subcutaneous Prime Elicits Th1 Dominant T-Cell and Humoral Responses in CD-1 Mice
A Rice, M Verma, A Shin, L Zakin, P Sieling, S Tanaka, J Balint, K Dinkins, ...
bioRxiv, 2021.03. 22.436476, 2021
52021
Single Prime Had5 Spike (s)+ Nucleocapsid (N) Dual Antigen Vaccination of Healthy Volunteers Induces a Ten-Fold Increase in Mean s-and N-T-Cell Responses Equivalent to T-Cell …
P Sieling, T King, R Wong, A Nguyen, K Wnuk, ER Gabitzsch, A Rice, ...
52021
Genetically modified non-human animals and methods relating to complement dependent cytotoxicity
LD Shultz, MK Verma, DL Greiner, MA Brehm
US Patent 10,701,911, 2020
12020
Endocrine therapy after aromatase inhibitor therapy in breast cancer
MK Verma, Y Miki, H Sasano
Expert Review of Endocrinology & Metabolism 6 (3), 309-312, 2011
12011
SmRNA PRIME S+ N DNA BOOST VACCINATION ELICITS ROBUST IMMUNE RESPONSES in MICE
A Rice, M Verma, E Voigt, P Battisti, S Beaver, K Dinkins, S Mody, ...
Topics in Antiviral Medicine, 92-92, 2022
2022
Heterologous Vaccination with SARS-CoV-2 Spike saRNA Prime followed by DNA Dual-Antigen Boost Induces Robust Antibody and T-Cell Immunogenicity against both Wild Type and Delta …
A Rice, M Verma, E Voigt, P Battisti, S Beaver, S Reed, K Dinkins, S Mody, ...
bioRxiv, 2021.11. 29.470440, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20